Same chart I keep posting (updated of course to yesterday's close):
Comparison of CHM (green/red candles) against NYSEARCA:IDNA (purple) & NASDAQ:CNCR (blue), ASX:IMU (orange).
IDNA and CNCR are immunotherapy ETFs.
ASX:XHJ (white) indicates sector rotation out of healthcare.
Biotech continues to get smashed whilst medical priorities are routed elsewhere, general bail out of speculative assets...
However, whenever this cycle is complete, a return to value-investing is probable. I don't have this skills to do fundamental analysis, but@DrillDown2014 had a go in this thread:
https://hotcopper.com.au/posts/52013032/single
Ann: CORE NK Platform Phase 1 Clinical Data Presentation, page-36
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
-0.002(10.0%) |
Mkt cap ! $15.41M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.8¢ | $91.77K | 5.013M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 762689 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 575678 | 3 |
View Market Depth
| Last trade - 12.23pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
1.8¢ |
Change
-0.002 ( 5.26 %) |
||||
| Open | High | Low | Volume | ||
| 1.8¢ | 2.0¢ | 1.8¢ | 3138580 | ||
| Last updated 12.36pm 30/05/2024 ? | |||||
| CHM (ASX) Chart |